he added: �these findings show that despite the tireless work of doctors and nurses, it appears that some cancer patients are still enduring shockingly long waits to start treatment.
.
“it may be just out of an abundance of caution and privacy. certainly, staying a little longer may imply that this is a little bit more of a complex situation.”
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.